Ambrosino N, Serradori M
Chron Respir Dis. 2006;3(3):117-22. doi: 10.1191/1479972306cd110ra.
Dyspnoea is the most common symptom of patients with cardio-respiratory diseases. It is a generic term related to different pathophysiological abnormalities that may result in different qualities of respiratory discomfort, defined by specific verbal descriptors for a specific diagnosis. Often it is difficult to distinguish the underlying pathology of dyspnoea, eg, either from chronic heart failure (CHF) or from other respiratory causes. The discovery of the endocrine function of the heart, as well as the development of accurate and feasible assay methods allow the use of cardiac natriuretic hormones in the assessment of cardiovascular diseases, namely acute coronary syndromes and heart failure. It is advisable to measure cardiac natriuretic hormones in order to exclude or suggest the diagnosis of CHF in patients with a suspicious diagnosis, but with ambiguous signs and symptoms or manifestations that can be confused with other pathologies (like chronic obstructive pulmonary disease). The most common symptom of patients with cardio-respiratory diseases is dyspnoea, a 'difficult, laboured, uncomfortable breathing'. Dyspnoea has been defined as 'a term used to characterize a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity. The experience derives from interactions among multiple physiological, psychological, social and environmental factors, and may induce secondary physiological and behavioural responses'. Breathlessness is characterized by measurable intensity and qualitative dimensions, which may vary depending on the individual, the underlying disease, and other circumstances.3 The neurophysiological basis of dyspnoea relies on receptors in the airways lung parenchyma, respiratory muscles together with chemoreceptors providing sensory feedback via vagal, phrenic and intercostal nerves to the spinal cord, medulla and higher centres. Breathlessness is based on different pathophysiolagical abnormalities that may result in different qualities of respiratory discomfort, which are defined by specific verbal descriptors related to a specific diagnosis. Nevertheless different diseases may share the same descriptors. There is no clear relationship between the qualitative descriptors of dyspnoea and the quantitative intensity among the patient groups: different diseases may be distinguished by quality but not intensity of the sensation. Differences in languages, in races, cultures, gender, and in the manner in which concepts or symptoms are held can all influence the idea, quality and intensity of dyspnoea.
呼吸困难是心肺疾病患者最常见的症状。它是一个通用术语,与不同的病理生理异常相关,这些异常可能导致不同性质的呼吸不适,通过特定的语言描述词来定义以进行特定诊断。通常很难区分呼吸困难的潜在病因,例如,是来自慢性心力衰竭(CHF)还是其他呼吸原因。心脏内分泌功能的发现以及准确可行的检测方法的发展,使得心脏利钠激素可用于评估心血管疾病,即急性冠状动脉综合征和心力衰竭。对于诊断可疑但体征和症状不明确或表现可能与其他疾病(如慢性阻塞性肺疾病)相混淆的患者,建议检测心脏利钠激素以排除或提示CHF的诊断。心肺疾病患者最常见的症状是呼吸困难,即“困难、费力、不舒服的呼吸”。呼吸困难被定义为“一个用于描述呼吸不适主观体验的术语,这种体验由强度不同的性质不同的感觉组成。这种体验源于多种生理、心理、社会和环境因素之间的相互作用,并可能引发继发性生理和行为反应”。呼吸急促的特点是具有可测量的强度和性质维度,这可能因个体、潜在疾病和其他情况而异。呼吸困难的神经生理基础依赖于气道、肺实质、呼吸肌中的感受器,以及化学感受器,它们通过迷走神经、膈神经和肋间神经向脊髓、延髓和更高的中枢提供感觉反馈。呼吸急促基于不同的病理生理异常,这些异常可能导致不同性质的呼吸不适,通过与特定诊断相关的特定语言描述词来定义。然而,不同的疾病可能有相同的描述词。在患者群体中,呼吸困难的定性描述词与定量强度之间没有明确的关系:不同的疾病可能通过感觉的性质而非强度来区分。语言、种族、文化、性别以及对概念或症状的理解方式的差异,都会影响呼吸困难的概念、性质和强度。